News

The review highlighted how recent advancements in oncology drugs and therapies have led to better outcomes for patients.

A randomized trial found that both Mat Pilates and belly dance programs led to significant gains in arm strength after breast cancer surgery.

Black patients with HR+, HER2 negative metastatic breast cancer were less likely to receive recommended therapy and had shorter survival.

Imlunestrant has received FDA approval for adults with ER-positive, HER2-negative breast cancer who have mutations in the ESR1 gene.

Breastfeeding appears to negatively correlate with breast cancer incidence, thus suggesting the existence of a protective effect.

Patients with cancer appear to be cautiously open to accepting AI-powered medical robots, provided they are complementary to human-led care.

Relay Therapeutics has received Breakthrough Therapy designation for zovegalisib and fulvestrant in PIK3CA mutant HR+/HER2- breast cancer.

Immunomic Therapeutics may now begin their clinical trial of ITI-5000, an RNA vaccine, in patients with triple-negative breast cancer.

Physically active women reported significantly higher body image and self-esteem than inactive participants, regardless of cancer history.

People diagnosed with cancer through routine screening report more short-term psychological distress compared to other diagnostic routes.